Clinical Trial Update: Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain [Phase 4]

View source ↗

Summary

Phase 4 trial investigating dronabinol for functional chest pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Diseases
• Functional Chest Pain

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Temple University | Conditions: Esophageal Diseases | Phase 4 | Status: WITHDRAWN